Enzyme vs TAC Protocol — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while TAC Protocol trades at Rp53.82 (market cap Rp265,75M, Rp103,91M 24h volume). The key difference: TAC Protocol is the larger of the two by market cap, and Enzyme's circulating supply is 3,3M MLN versus 4,8B TAC for TAC Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and TAC Protocol for 4 Days on average.
| MLN | TAC | |
|---|---|---|
Market Cap | Rp134,13M | Rp265,75M |
Volume (24h) | Rp104,56M | Rp103,91M |
Circulating Supply | 3,3M MLN | 4,8B TAC |
Typical Hold Time | 28 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
TAC Protocol trades at Rp55.268 with a market cap of Rp267.36M, showing a bearish technical signal overall. The asset's hold time is 4 days, and moving averages indicate strong selling pressure. RSI levels show mixed signals, with RSI_12 at 9.90 suggesting potential oversold conditions. Support levels are at Rp40, Rp44, and Rp48, while resistance lies at Rp56, Rp60, and Rp64. No major protocol updates or ecosystem developments were noted in recent crypto-specific news.
The outlook remains cautious due to bearish technical indicators and low market cap, which may increase volatility. Key opportunities include potential rebounds from oversold RSI levels near support zones. Major risks involve low liquidity, regulatory uncertainty for cryptocurrencies, and limited on-chain activity. Investors should monitor for any upcoming protocol announcements or exchange listings that could impact price action.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →TAC is the first EVM-compatible blockchain built specifically for the TON ecosystem and Telegram. It delivers full DeFi functionality from day one with EVM infrastructure, pre-deployed blue-chip DeFi apps, and liquidity from Ethereum and BTC.
Read more on TAC →